Market Overview

Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest ROA

Share:
Related UTHR
Every Biotech Catalyst Wedbush Is Watching In 2016
Mid-Morning Market Update: Markets Down; Ford Earnings Miss Views
Related RDY
Dr. Reddy's Receives FDA Tentative Approval For Zenavod Capsules
Dr. Reddy's Receives FDA Tentative Approval for Zenavod Capsules, 40 mg for Treatment of Rosacea in Adults
FDA clears Dr. Reddy's betamethasone spray for psoriasis (Seeking Alpha)

Below are the top mid-cap drug manufacturers-other stocks on the NYSE and the NASDAQ in terms of return on assets.

The trailing-twelve-month return on equity at United Therapeutics (NASDAQ: UTHR) is 15.87%. United Therapeutics' operating margin for the same period is 43.33%.

The trailing-twelve-month return on equity at Warner Chilcott plc (NASDAQ: WCRX) is 11.92%. Warner Chilcott's revenue for the same period is $2.45 billion.

The trailing-twelve-month return on equity at Dr. Reddy's Laboratories (NYSE: RDY) is 9.82%. Dr. Reddy's PEG ratio is 1.29.

The trailing-twelve-month return on equity at Endo Health Solutions (NASDAQ: ENDP) is 8.04%. Endo Health had $340.52 million in total cash for the latest quarter.

Posted-In: Drug Manufacturers-Other Industry Highest ROA mid-cap stocksTrading Ideas

 

Related Articles (ENDP + RDY)

View Comments and Join the Discussion!

Get Benzinga's Newsletters